{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:43:07Z","timestamp":1792788187787,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T00:00:00Z","timestamp":1581552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Major Science and Technology in Key New Drugs Creation","award":["2012ZX09104-203"],"award-info":[{"award-number":["2012ZX09104-203"]}]},{"DOI":"10.13039\/100000185","name":"\"111\" project","doi-asserted-by":"publisher","award":["B08006"],"award-info":[{"award-number":["B08006"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and purpose<\/jats:title>\n                    <jats:p>Tianzhi granule (TZ) is usually used for patients with vascular dementia (VaD) in China. The aim was to assess the effect of TZ by a randomized clinical trial (RCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A 24-week RCT was conducted in 16 centres. Participants were grouped into TZ, donepezil or placebo. The co-primary outcomes were the Vascular Dementia Assessment Scale-cognitive subscale (VADAS-cog) and Clinician\u2019s Interview-based Impression of Change-plus caregiver information (CIBIC-plus).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 543 patients with mild to moderate VaD were enrolled, of whom 242 took TZ granules, 241 took donepezil, and 60 took placebo. The least-squares mean changes from baseline and 95% CI were 6.20\u00a0(5.31,\u00a07.09) (TZ group),\u00a06.53\u00a0(5.63,\u00a07.42)\u00a0(donepezil group) and 3.47\u00a0(1.76,\u00a05.19) (placebo group), both TZ and donepezil showed small but significantly improvement compared with placebo group.\u00a0The percent of improvement on the global impression which was measured by CIBIC-plus was 73.71% in TZ and 58.18% in placebo, there was significant different between TZ and placebo group (P = 0.004). No significant differences were observed between TZ and donepezil. No significant differences of adverse events were found.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TZ\u00a0and donepezil could bring symptomatic benefit for mild to moderate VaD.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      The protocol had retrospectively registered at clinical trial.gov, Unique identifier: NCT02453932, date of registration: May 27, 2015;\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02453932?term=NCT02453932&amp;rank=1\">https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02453932?term=NCT02453932&amp;rank=1<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-020-02232-z","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T05:03:28Z","timestamp":1581570208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial"],"prefix":"10.1186","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct02453932","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Jing","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuguang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanzhao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanping","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baorong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengchun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanjin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1607-5897","authenticated-orcid":false,"given":"Jinzhou","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The CHASE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,13]]},"reference":[{"key":"2232_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000054785","volume":"20","author":"MF Dubois","year":"2001","unstructured":"Dubois MF, H\u00e9bert R. The incidence of vascular dementia in Canada: a comparison with Europe and East Asia. Neuroepidemiology. 2001;20:179\u201387.","journal-title":"Neuroepidemiology"},{"key":"2232_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jns.2010.08.055","volume":"299","author":"LT Grinberg","year":"2010","unstructured":"Grinberg LT, Heinsen H. Toward a pathological definition of vascular dementia. J Neurol Sci. 2010;299:136\u20138.","journal-title":"J Neurol Sci"},{"key":"2232_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jns.2007.01.081","volume":"257","author":"AD Korczyn","year":"2007","unstructured":"Korczyn AD, Vakhapova V. The prevention of the dementia epidemic. J Neurol Sci. 2007;257:2\u20134.","journal-title":"J Neurol Sci"},{"key":"2232_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S1474-4422(05)70221-0","volume":"4","author":"D Leys","year":"2005","unstructured":"Leys D, H\u00e9non H, Mackowiak-Cordoliani MA, Pasquier F. Post stroke dementia. Lancet Neurol. 2005;4:752\u20139.","journal-title":"Lancet Neurol."},{"issue":"10","key":"2232_CR5","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.jocn.2012.01.029","volume":"19","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Xu Y, Nie H, et al. Prevalence of dementia and major dementia subtypes in the Chinese populations: a meta-analysis of dementia prevalence surveys, 1980\u20132010.\u00a0J Clin Neurosci.\u00a02012;19(10):1333\u20137","journal-title":"J Clin Neurosci."},{"key":"2232_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2013.01.012","volume":"10","author":"J Jia","year":"2014","unstructured":"Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement 2014;10:1\u20139","journal-title":"Alzheimers Dement"},{"key":"2232_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/S1474-4422(07)70195-3","volume":"6","author":"H Kavirajan","year":"2007","unstructured":"Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomized controlled trials. Lancet Neurol. 2007;6:782\u201392.","journal-title":"Lancet Neurol."},{"key":"2232_CR8","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/j.1532-5415.2004.52356.x","volume":"52","author":"KM Sink","year":"2004","unstructured":"Sink KM, Covinsky KE, Newcomer R, Yaffe K. Ethnic differences in the prevalence and pattern of dementia-related behaviors. J Am Geriatr Soc. 2004;52:1277\u201383.","journal-title":"J Am Geriatr Soc"},{"key":"2232_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1041610204000468","volume":"16","author":"W Black","year":"2004","unstructured":"Black W, Almeida OP. A systematic review of the association between the Behavioral and Psychological Symptoms of Dementia and burden of care. Int Psychogeriatr. 2004;16:295\u2013315.","journal-title":"Int Psychogeriatr"},{"key":"2232_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/089198879600900303","volume":"9","author":"E Magni","year":"1996","unstructured":"Magni E, Binetti G, Bianchetti A, Trabucchi M. Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol. 1996;9:123\u20136.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"2232_CR11","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.1997.03540340040030","volume":"227","author":"Y Stern","year":"1997","unstructured":"Stern Y, Tang M-X, Albert MS, Brandt J, Jacobs DM, Bell K, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA. 1997;227:806\u201381.","journal-title":"JAMA"},{"key":"2232_CR12","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","volume":"168","author":"CL Vigen","year":"2011","unstructured":"Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, et al. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2019s disease: outcomes from CATIE-AD. Am J Psychiatry. 2011;168:831\u20139.","journal-title":"Am J Psychiatry"},{"key":"2232_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","volume":"72","author":"DT Maust","year":"2015","unstructured":"Maust DT, Kim HM, Seyfried LS, Chiang C, Kavanagh J, Schneider LS, et al. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm. JAMA Psychiatry. 2015;72:438\u201345.","journal-title":"JAMA Psychiatry."},{"issue":"5","key":"2232_CR14","first-page":"393","volume":"6","author":"BA Zhang","year":"2006","unstructured":"Zhang BA, Gao L, Chen LR, Li WT, Liu YR, Jia YJ, Wu WP. Effect of Tianzhi granule on the proliferation of intracranial nerve cells in vascular dementia rats. Chinese J Contemp Neurol Neurosurg. 2006;6(5):393\u20137.","journal-title":"Chinese J Contemp Neurol Neurosurg."},{"key":"2232_CR15","first-page":"73","volume":"28","author":"GY Du","year":"2003","unstructured":"Du GY, Zhu XC, Zhao JJ, Wang J, Tian JZ, Liu XF, et al. Clinical study of effect of tianzhi granule on senile vascular dementia. Zhongguo Zhong Yao Za Zhi. 2003;28:73\u20137.","journal-title":"Zhongguo Zhong Yao Za Zhi."},{"issue":"6","key":"2232_CR16","first-page":"366","volume":"32","author":"BH Wang","year":"2015","unstructured":"Wang BH, Che YH, Ding HY. Meta-analysis on the effect of Tianzhi Keli in treatment of vascular dementia. Chin J Drug Eval. 2015;32(6):366\u20139.","journal-title":"Chin J Drug Eval."},{"key":"2232_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1212\/WNL.43.2.250","volume":"43","author":"GC Rom\u00e1n","year":"1993","unstructured":"Rom\u00e1n GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250\u201360.","journal-title":"Neurology."},{"key":"2232_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975;12:189\u201398.","journal-title":"J Psychiat Res."},{"key":"2232_CR19","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","volume":"32","author":"VC Hachinski","year":"1975","unstructured":"Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, McAllister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol. 1975;32:632\u20137.","journal-title":"Arch Neurol"},{"key":"2232_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"Suppl 1","key":"2232_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1017\/S1041610203009220","volume":"15","author":"SH Ferris","year":"2003","unstructured":"Ferris SH. General measures of cognition. Int Psychogeriatr. 2003;15(Suppl 1):215\u20137.","journal-title":"Int Psychogeriatr"},{"key":"2232_CR22","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","volume":"141","author":"WG Rosen","year":"1984","unstructured":"Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer\u2019s disease. Am J Psychiatry. 1984;141:1356\u201364.","journal-title":"Am J Psychiatry"},{"key":"2232_CR23","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000103865","volume":"24","author":"R Ylikoski","year":"2007","unstructured":"Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, et al. Comparison of the Alzheimer\u2019s Disease Assessment Scale Cognitive Subscale and the vascular dementia assessment scale in differentiating elderly individuals with different degrees of white matter changes. Dement Geriatr Cogn Disord. 2007;24:73\u201381.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2232_CR24","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00002093-199700112-00004","volume":"11","author":"L Schneider","year":"1997","unstructured":"Schneider L, Olin J, Doody R, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimers Disease cooperative study\u2013clinical global impression of change. Alzheimer Dis Assoc Disord. 1997;11:S1\u201312.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2232_CR25","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thomson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308\u201314.","journal-title":"Neurology."},{"issue":"Suppl 3","key":"2232_CR26","doi-asserted-by":"publisher","first-page":"iii41","DOI":"10.1093\/ageing\/afs149","volume":"41","author":"B Agrell","year":"2012","unstructured":"Agrell B, Dehlin O. The clock-drawing test. 1998. Age Ageing. 2012;41(Suppl 3):iii41\u20135.","journal-title":"Age Ageing."},{"key":"2232_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jgs.15135","volume":"66","author":"M Wei","year":"2018","unstructured":"Wei M, Shi J, Li T, Ni J, Zhang X, Li Y, et al. Diagnostic accuracy of the Chinese version of the trail-making test for screening cognitive impairment. J Am Geriatr Soc. 2018;66:92\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"2232_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","volume":"9","author":"MP Lawton","year":"1969","unstructured":"Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179\u201386.","journal-title":"Gerontologist."},{"key":"2232_CR29","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/STROKEAHA.109.570077","volume":"41","author":"GC Rom\u00e1n","year":"2010","unstructured":"Rom\u00e1n GC, Salloway S, Black SE, Royall DR, Decarli C, Weiner MW, Moline M, Kumar D, Schindler R, Posner H. Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size. Stroke. 2010;41:1213\u201321.","journal-title":"Stroke"},{"key":"2232_CR30","first-page":"14099","volume":"8","author":"Y Li","year":"2015","unstructured":"Li Y, Zhang Z. Gastrodin improves cognitive dysfunction and decreases oxidative stress in vascular dementia rats induced by chronic ischemia. Int J Clin Exp Pathol. 2015;8:14099\u2013109.","journal-title":"Int J Clin Exp Pathol."},{"key":"2232_CR31","first-page":"604","volume":"40","author":"LJ Li","year":"2009","unstructured":"Li LJ, Li HX, Wu XT, Yan B, Zhou D. Effect of geniposide on vascular dementia in rats. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40:604\u20137.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban."},{"key":"2232_CR32","first-page":"273","volume":"14","author":"BA Zhang","year":"2008","unstructured":"Zhang BA, Chen LR, Gao L, Wu WP, Liu HB, Fang SY. Effects of Tianzhi granule on proliferation of neuroglial cells in chronic cerebral ischemic rats. Chin J Basic Med Tradit Chin Med. 2008;14:273\u20134.","journal-title":"Chin J Basic Med Tradit Chin Med"},{"issue":"4","key":"2232_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/01.WNL.0000078943.50032.FC","volume":"61","author":"D Wilkinson","year":"2003","unstructured":"Wilkinson D, Doody R, Helme R, Taubman K, Mintzer J, Kertesz A, Pratt RD, Donepezil 308 Study Group. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology. 2003;61(4):479\u201386.","journal-title":"Neurology."},{"key":"2232_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000088494","volume":"20","author":"GC Rom\u00e1n","year":"2005","unstructured":"Rom\u00e1n GC, Wilkinson DG, Doody RS, Black SE, Salloway SP, Schindler RJ. Donepezil in vascular dementia: combined analysis of two large-scale clinical trials. Dement Geriatr Cogn Disord. 2005;20:338\u201344.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"2232_CR35","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2147\/cia.s4250","volume":"3","author":"N Campbell","year":"2008","unstructured":"Campbell N, Ayub A, Boustani MA, et al. Impact of cholinesterase inhibitors on behavioral and psychological symptoms of Alzheimer\u2019s disease: a meta-analysis. Clin Interv Aging. 2008;3(4):719\u2013728. https:\/\/doi.org\/10.2147\/cia.s4250.","journal-title":"Clin Interv Aging."},{"key":"2232_CR36","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","volume":"33","author":"J-M Orgogozo","year":"2002","unstructured":"Orgogozo J-M, Rigaud A-S, Sto\u0308ffler A, Mo\u0308bius H-J, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia. Stroke 2002;33(7):1834\u20139","journal-title":"Stroke"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02232-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02232-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T12:21:27Z","timestamp":1628598087000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02232-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,13]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2232"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02232-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,13]]},"assertion":[{"value":"27 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Medical Ethics Committee of Beijing Anzhen Hospital and the Medical Ethics Committee of the study institutions where this study was conducted. Written informed consent was provided by the patients and their legal representatives.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"XF Liu, F Sun are employees of Zhongjing Wanxi Pharmaceutical Co., Ltd, Zhongjing Wanxi Pharmaceutical Co., Ltd supplied the study drugs for this clinical trial, other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}